Home/Filings/4/0001061983-11-000011
4//SEC Filing

MORGANS DAVID J JR 4

Accession 0001061983-11-000011

CIK 0001061983other

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 6:28 PM ET

Size

27.0 KB

Accession

0001061983-11-000011

Insider Transaction Report

Form 4
Period: 2011-02-28
MORGANS DAVID J JR
EVP-Preclinical R&D
Transactions
  • Award

    Incentive Stock Option (right to buy)

    2011-02-28+51,04351,043 total
    Exercise: $1.57From: 2011-03-31Exp: 2021-02-28Common Stock (51,043 underlying)
  • Award

    Non-Qualified Stock Option (right to buy)

    2011-02-28+123,957123,957 total
    Exercise: $1.57From: 2011-03-31Exp: 2021-02-28Common Stock (123,957 underlying)
Holdings
  • Non-Qualified Stock Option (right to buy)

    Exercise: $3.37From: 2008-03-29Exp: 2018-02-28Common Stock (122,286 underlying)
    122,286
  • Non-Qualified Stock Option (right to buy)

    Exercise: $7.15From: 2006-03-01Exp: 2016-03-01Common Stock (44,612 underlying)
    44,612
  • Incentive Stock Option (right to buy)

    Exercise: $6.81From: 2007-04-01Exp: 2017-03-14Common Stock (14,810 underlying)
    14,810
  • Incentive Stock Option (right to buy)

    Exercise: $1.85From: 2009-03-26Exp: 2019-02-26Common Stock (43,751 underlying)
    43,751
  • Incentive Stock Option (right to buy)

    Exercise: $3.08From: 2010-03-24Exp: 2020-02-24Common Stock (37,442 underlying)
    37,442
  • Incentive Stock Option (right to buy)

    Exercise: $3.37From: 2008-03-29Exp: 2018-02-28Common Stock (27,714 underlying)
    27,714
  • Incentive Stock Option (right to buy)

    Exercise: $6.59From: 2005-04-11Exp: 2015-04-11Common Stock (35,995 underlying)
    35,995
  • Non-Qualified Stock Option (right to buy)

    Exercise: $3.08From: 2010-03-24Exp: 2020-02-24Common Stock (97,558 underlying)
    97,558
  • Non-Qualified Stock Option (right to buy)

    Exercise: $6.59From: 2005-04-11Exp: 2015-04-11Common Stock (14,005 underlying)
    14,005
  • Incentive Stock Option (right to buy)

    Exercise: $7.15From: 2006-03-01Exp: 2016-03-01Common Stock (15,388 underlying)
    15,388
  • Non-Qualified Stock Option (right to buy)

    Exercise: $6.81From: 2007-04-01Exp: 2017-03-14Common Stock (50,190 underlying)
    50,190
  • Common Stock

    42,000
  • Incentive Stock Option (right to buy)

    Exercise: $6.50From: 2004-04-08Exp: 2014-03-08Common Stock (34,000 underlying)
    34,000
  • Non-Qualified Stock Option (right to buy)

    Exercise: $1.85From: 2009-03-26Exp: 2019-02-26Common Stock (106,249 underlying)
    106,249
Footnotes (8)
  • [F1]When the ISO and NQ dated 02/28/2011 are combined for a total grant of 175,000 shares, the option shall vest and become exercisable as to 3,645 shares on 03/31/2011 and the balance of 171,355 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/28/2015.
  • [F2]When the ISO and NQ dated 02/26/2009 are combined for a total grant of 150,000 shares, the option shall vest and become exercisable as to 3,125 shares on 03/26/09 and the balance of 146,875 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/26/13.
  • [F3]When the ISO and NQ dated 02/24/2010 are combined for a total grant of 135,000 shares, the option shall vest and become exercisable as to 2,812 shares on 03/24/2010 and the balance of 132,188 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/24/2014.
  • [F4]When the ISO and NQ dated 02/29/2008 are combined for a total grant of 150,000 shares, the option shall vest and become exercisable as to 3,125 shares on 03/29/08 and the balance of 146,875 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/29/12.
  • [F5]This option shall vest and become exercisable as to 708 shares on 04/08/04 and the balance of 33,292 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/08/08.
  • [F6]When the ISO and NQ dated 04/11/05 are combined for a total grant of 50,000 shares, the option shall vest and become exercisable as to 50,000 shares divided into equal monthly installments such that the option shall be 100% vested on 03/01/2009.
  • [F7]When the ISO and NQ dated 03/14/2007 are combined for a total grant of 65,000 shares, the option shall vest and become exercisable as to 1,354 shares on 04/01/07 and the balance of 63,646 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/01/11.
  • [F8]When the ISO and NQ dated 03/01/2006 are combined for a total grant of 60,000 shares, the option shall vest and become exercisable as to 60,000 shares divided into equal monthly installments such that the option shall be 100% vested on 03/01/2010.

Issuer

CYTOKINETICS INC

CIK 0001061983

Entity typeother

Related Parties

1
  • filerCIK 0001288528

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 6:28 PM ET
Size
27.0 KB